Eosinophilic Cellulitis
Wells syndrome is an uncommon skin condition marked by sudden flares of firm, red, swollen plaques that can be painful or intensely itchy. Clinically it can look almost identical to bacterial cellulitis, yet it is not an infection at all: it is a non-infectious inflammatory reaction driven by a dense influx of eosinophils into the dermis.
At Haute-Derma, we manage Wells syndrome by combining histopathologic diagnosis with targeted immunomodulation. Our first priority is to tell it apart from ordinary skin infections so that patients are spared unnecessary antibiotics, and then to bring the inflammation under control quickly before the skin damage spreads.
Our Approach to Treating Wells Syndrome
Our specialists know how unsettling Wells syndrome can be, because the red, inflamed plaques tend to spread very quickly. We start by looking for "flame figures" in the skin biopsy, the key histologic finding that confirms the diagnosis.
Calming the skin is only part of the job. We also look for possible triggers such as drug reactions, insect bites or an associated systemic disorder. At Haute-Derma, each treatment plan is tailored to control acute flares and to put preventive measures in place that reduce the risk of long-term recurrence.
Our Wells syndrome care pathway includes:
- Skin biopsy with special stains to identify the characteristic eosinophilic infiltrate.
- Systemic immunomodulatory therapy to rapidly dampen the cytokine-driven inflammation.
- Skin barrier repair once the acute inflammatory phase has settled.
How We Diagnose Wells Syndrome at Haute-Derma
To avoid confusion with other skin conditions, Haute-Derma uses a step-by-step diagnostic process:
- Clinical assessment: We look for firm, indurated plaques that are bright red or violaceous, usually well demarcated, and warm and tender in the same way as cellulitis.
- Tracking color changes: The plaques typically fade from red to a slate-gray or greenish-yellow hue before clearing completely without scarring.
- Blood tests: We monitor the peripheral blood eosinophil count, which is often raised during the acute phase.
- Detailed histopathology: We look for "flame figures": degenerated collagen fibers coated with toxic granule proteins released by eosinophils.
- Screening for triggers: We review medication history, insect exposure and the possibility of an underlying malignancy.
How Is Wells Syndrome Treated at Haute-Derma?
Our treatment protocol aims to suppress eosinophil activation and calm the tissue reaction:
- Systemic corticosteroids: Our first choice for bringing severe flares under control quickly. They reduce pain and swelling and shrink the plaques within a few days.
- Anti-IL-5 biologic therapy (mepolizumab): Used for chronic or frequently relapsing disease to keep eosinophil levels down over the long term without the need for high-dose corticosteroids.
- Newer-generation antihistamines: Help relieve itching and limit local hypersensitivity reactions.
- Dapsone or cyclosporine: May be considered as maintenance therapy to prevent relapses in susceptible patients.
- Skin recovery care: Haute-Derma's specialized dermocosmetic products are used to soothe the skin and minimize post-inflammatory hyperpigmentation.
